Search research articles
Contact Us
Filters
Showing results (91-100 of 134) with videos related to
Page
of 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2023
Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer
Kathy Han, Jinfeng Zou, Zhen Zhao, et al.
Nature Communications
|
March 16, 2023
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma
Ainhoa Madariaga, Swati Garg, Nairi Tchrakian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2025
ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous Carcinoma
Joyce F Liu, Nicoletta Colombo, Amit M Oza, et al.
BMC Cancer
|
March 19, 2025
Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor)
Daniel Marbach, Jurriaan Brouer-Visser, Laura Brennan, et al.
Genome Medicine
|
November 2, 2018
Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors
S Y Cindy Yang, Stephanie Lheureux, Katherine Karakasis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2020
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression
Stephanie Lheureux, Ana Oaknin, Swati Garg, et al.
Journal of Oncology Practice
|
September 25, 2019
Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic Cancer
Yeh Chen Lee, Nazlin Jivraj, Lisa Wang, et al.
Journal of the National Cancer Institute
|
May 6, 2024
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)
Elisa Fontana, Ezra Rosen, Elizabeth K Lee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancers
Ainhoa Madariaga, Nazlin Jivraj, Pamela Soberanis Pina, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 31, 2024
Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancers
Ainhoa Madariaga, Nazlin Jivraj, Pamela Soberanis Pina, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 134) with videos related to
Sort By:
Page
of 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2023
Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer
Kathy Han, Jinfeng Zou, Zhen Zhao, et al.
Nature Communications
|
March 16, 2023
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma
Ainhoa Madariaga, Swati Garg, Nairi Tchrakian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2025
ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous Carcinoma
Joyce F Liu, Nicoletta Colombo, Amit M Oza, et al.
BMC Cancer
|
March 19, 2025
Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor)
Daniel Marbach, Jurriaan Brouer-Visser, Laura Brennan, et al.
Genome Medicine
|
November 2, 2018
Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors
S Y Cindy Yang, Stephanie Lheureux, Katherine Karakasis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2020
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression
Stephanie Lheureux, Ana Oaknin, Swati Garg, et al.
Journal of Oncology Practice
|
September 25, 2019
Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic Cancer
Yeh Chen Lee, Nazlin Jivraj, Lisa Wang, et al.
Journal of the National Cancer Institute
|
May 6, 2024
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)
Elisa Fontana, Ezra Rosen, Elizabeth K Lee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancers
Ainhoa Madariaga, Nazlin Jivraj, Pamela Soberanis Pina, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 31, 2024
Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancers
Ainhoa Madariaga, Nazlin Jivraj, Pamela Soberanis Pina, et al.
Page
of 14